Anavex Life Sciences (AVXL) Tops Q3 EPS by 3c

Anavex Life Sciences (NASDAQ: AVXL) reported Q3 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
• Live Ventures (LIVE) Reports Q3 Loss of $0.34